Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,792 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00661778 | A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01240447 | Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients | completed | Phase 2 | 7 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01996332 | A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 1,805 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT00620971 | Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC | completed | Phase 2 | 77 | Hellenic Oncology Research GroupOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00118235 | Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00368927 | Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia | completed | Phase 2 | 61 | National Cancer Institute (NCI)NIH | 2 | May 23, 2014 | clinicaltrials |
| NCT00182689 | Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 89 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00778167 | Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT01004250 | A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer | completed | Phase 2 | 109 | Eli Lilly and CompanyINDUSTRY | 5 | May 21, 2014 | clinicaltrials |
| NCT01362400 | A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 226 | Infinity Pharmaceuticals, Inc.INDUSTRY | 6 | May 19, 2014 | clinicaltrials |
| NCT00066742 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00079040 | Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | May 14, 2014 | clinicaltrials |
| NCT00773955 | R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | May 12, 2014 | clinicaltrials |
| NCT00406302 | Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 41 | Wolfgang HilbeOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT00616109 | Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC | completed | Phase 2 | 16 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00086827 | Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2014 | clinicaltrials |
| NCT01000480 | A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer | completed | Phase 2 | 90 | Eli Lilly and CompanyINDUSTRY | 4 | Apr 2, 2014 | clinicaltrials |
| NCT00730925 | Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients | completed | Phase 2 | 41 | Boehringer IngelheimINDUSTRY | 2 | Mar 26, 2014 | clinicaltrials |
| NCT00247416 | Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer | completed | Phase 2 | 60 | Susanne ArnoldOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00995761 | Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 48 | Gyeongsang National University HospitalOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01516983 | Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation | completed | Phase 1 / Phase 2 | 15 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT00256815 | Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study | completed | Phase 1 / Phase 2 | 35 | Clinical Oncology Research AssociatesOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00171834 | Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 89 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00246181 | Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC(SBF-NSCLC) | completed | Phase 1 / Phase 2 | 117 | Jill DelucaOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00487669 | Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 14 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT01003899 | A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR] | completed | Phase 2 | 43 | Boehringer IngelheimINDUSTRY | 1 | Dec 31, 2013 | clinicaltrials |
| NCT01017679 | Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg | completed | Phase 2 | 96 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01561456 | Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung | completed | Phase 2 | 100 | Axelar ABINDUSTRY | 5 | Dec 5, 2013 | clinicaltrials |
| NCT00600821 | A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. | completed | Phase 2 | 118 | PfizerINDUSTRY | 6 | Nov 8, 2013 | clinicaltrials |
| NCT00828841 | Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC | completed | Phase 2 | 601 | Accelerated Community Oncology Research NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01528488 | Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC | completed | Phase 2 / Phase 3 | 118 | Sun Yat-sen UniversityOTHER | 1 | Nov 5, 2013 | clinicaltrials |
| NCT00101413 | BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) | completed | Phase 2 | 52 | BayerINDUSTRY | 2 | Oct 30, 2013 | clinicaltrials |
| NCT00147537 | Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer | completed | Phase 1 / Phase 2 | 282 | PfizerINDUSTRY | 4 | Oct 30, 2013 | clinicaltrials |
| NCT00413283 | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 63 | AmgenINDUSTRY | 8 | Oct 24, 2013 | clinicaltrials |
| NCT00052949 | Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 91 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01086254 | SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer | completed | Phase 2 | 119 | SanofiINDUSTRY | 5 | Sep 24, 2013 | clinicaltrials |
| NCT01368848 | Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) | completed | Phase 2 | 7 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00922584 | Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor | completed | Phase 2 | 65 | Chinese Society of Lung CancerOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT00583830 | A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 111 | Human Genome Sciences Inc.INDUSTRY | 4 | Aug 8, 2013 | clinicaltrials |
| NCT00092924 | Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | Human Genome Sciences Inc.INDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00079235 | CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00702975 | Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy | completed | Phase 2 | 35 | Radboud University Medical CenterOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT00463515 | Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC(CHER@NOS) | completed | Phase 2 | 77 | University Hospital, AntwerpOTHER | 1 | Jul 12, 2013 | clinicaltrials |
| NCT00529100 | Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00600587 | Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 24 | Guangdong Provincial People's HospitalOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00871403 | Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 2 | Jun 20, 2013 | clinicaltrials |
| NCT00452634 | Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) | completed | Phase 2 | 62 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00536640 | Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab(INNOVATIONS) | completed | Phase 2 | 224 | Aktion Bronchialkarzinom e.V.OTHER | 1 | Jun 12, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 10, 2014source: clinicaltrials